Patent Yard Sign in
Expired Canadian patentCanada

Hydrolysed milk proteins for dialysis procedures

CA 1341175 C · Owner: Gilchrist, Thomas · Inventors: Gilchrist, Thomas; Manson, William

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A medicinal composition, particularly but not exclusively for use in fluids for medical dialysis contains, as an agent, for maintaining the osmolality of the fluid a protein, hydrolysate resulting from the action of a proteolytic enzyme on the sodium caseinate fraction of milk protein. The enzyme is preferably trypsin but other proteolytic enzymes and enzyme mixtures may be used, examples being chymotrypsin pancreatin, and pronase. The method of production involves treating the sodium caseinate in aqueous medium with the enzyme at the appropriate pH and temperature for optimum enzyme activity. The product of the enzymic hydrolysis after filtration through, a bacterial filter adjustment of …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted January 30, 2001. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended January 30, 2018.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 2, 1986
GrantedJanuary 30, 2001
Term endedJanuary 30, 2018
Patent numberCA 1341175 C
Classification (IPC)A61M1/14 +2 more

Timeline

Timeline From CIPO dates

19871991199519992003200720112015Application filedSep 2, 1986Patent grantedJan 30, 2001Term endedJan 30, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.